Healthcare -
Biotechnology - NASDAQ - US
$ 3.6301
4.61 %
$ 2.65 B
Market Cap
-4.03
P/E
IBRX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities IBRX - ImmunityBio, Inc.
-30.5 M
LAST VALUE
40.09%
2 YEAR CAGR
-8.93%
5 YEAR CAGR
-151.58%
10 YEAR CAGR